Trial Profile
Clinical Trials Insight: 700020776
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2007
Price :
$35
*
At a glance
- Drugs Arimoclomol (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- Sponsors CytRx Corporation
- 25 Jun 2007 Results have been reported by CytRx.
- 08 Feb 2007 New trial record.